Advent Pharma Ltd. (DSE: ADVENT)

Market Cap	1.60B
Revenue (ttm)	571.67M
Net Income (ttm)	83.99M
Shares Out	93.13M
EPS (ttm)	0.90
PE Ratio	19.11
Forward PE	n/a
Dividend	0.20 (1.16%)
Ex-Dividend Date	Nov 21, 2024

Volume	1,300,373
Open	n/a
Previous Close	16.50
Day's Range	16.00 - 17.30
52-Week Range	13.90 - 35.60
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 28, 2024

About Advent Pharma

Advent Pharma Ltd., a pharmaceutical company, manufactures, imports, and markets animal health care drugs, nutritional supplements, and feed additives for livestock in Bangladesh. The company offers poultry, aquaculture, and cattle products. It provides products in powder, bolus, and liquid dosage forms. The company was incorporated in 2007 and is based in Dhaka, Bangladesh.

• Industry: Pharmaceutical Preparations
• Founded: 2007
• Employees: 317
• Stock Exchange: Dhaka Stock Exchange
• Ticker Symbol: ADVENT

Financial Performance

In 2023, Advent Pharma's revenue was 558.05 million, an increase of 5.20% compared to the previous year's 530.47 million. Earnings were 98.64 million, an increase of 1.14%.